Sagimet Biosciences Inc.SGMTNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+22.4%
5Y CAGR+37.9%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+22.4%/yr
Annual compound
5Y CAGR
+37.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$56.89M+4.5%
2024$54.45M+66.3%
2023$32.74M+5.4%
2022$31.05M+30.9%
2021$23.72M+108.1%
2020$11.40M-19.0%
2019$14.07M-